Koninklijke Philips Goodwill and Intangible Assets 2010-2024 | PHG

Koninklijke Philips goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
  • Koninklijke Philips goodwill and intangible assets for the quarter ending September 30, 2024 were $14.351B, a 13.81% decline year-over-year.
  • Koninklijke Philips goodwill and intangible assets for 2023 were $14.141B, a 2.49% decline from 2022.
  • Koninklijke Philips goodwill and intangible assets for 2022 were $14.502B, a 14.21% decline from 2021.
  • Koninklijke Philips goodwill and intangible assets for 2021 were $16.903B, a 34.39% increase from 2020.
Koninklijke Philips Annual Goodwill and Intangible Assets
(Millions of US $)
2023 $14,141
2022 $14,502
2021 $16,903
2020 $12,578
2019 $13,574
2018 $14,281
2017 $12,493
2016 $13,777
2015 $13,565
2014 $13,992
2013 $12,972
2012 $13,734
2011 $15,338
2010 $16,245
2009 $16,070
Koninklijke Philips Quarterly Goodwill and Intangible Assets
(Millions of US $)
2024-06-30 $14,351
2023-06-30 $14,571
2023-03-31
2022-06-30 $16,534
2021-06-30 $16,651
2020-06-30 $13,080
2019-06-30 $13,657
2018-06-30 $13,640
2017-06-30 $10,111
2016-12-31 $13,777
2016-09-30 $13,305
2016-06-30 $13,541
2016-03-31 $13,008
2015-12-31 $13,565
2015-09-30 $13,270
2015-06-30 $13,587
2015-03-31 $14,200
2014-12-31 $13,992
2014-09-30 $13,846
2014-06-30 $13,356
2014-03-31 $13,257
2013-12-31 $12,972
2013-09-30 $13,319
2013-06-30 $13,640
2013-03-31 $14,168
2012-12-31 $13,734
2012-09-30 $13,789
2012-06-30 $14,587
2012-03-31 $14,156
2011-12-31 $15,338
2011-09-30 $14,866
2011-06-30 $14,354
2011-03-31 $15,789
2010-12-31 $16,245
2010-09-30 $15,437
2010-06-30 $16,846
2010-03-31 $16,841
2009-12-31 $16,070
2009-09-30 $16,303
2009-06-30 $16,081
2009-03-31 $15,823
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $24.269B $19.663B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $194.797B 24.85
Boston Scientific (BSX) United States $139.837B 40.20
Stryker (SYK) United States $139.395B 31.41
EssilorLuxottica (ESLOY) France $110.104B 0.00
Medtronic (MDT) Ireland $103.429B 15.36
Lonza Group Ag (LZAGY) Switzerland $43.664B 0.00
Haleon (HLN) United Kingdom $41.193B 26.76
GE HealthCare Technologies (GEHC) United States $38.725B 20.09
ResMed (RMD) United States $34.324B 28.21
Terumo (TRUMY) Japan $28.025B 39.58
Zimmer Biomet Holdings (ZBH) United States $20.811B 13.25
Insulet (PODD) United States $19.068B 75.93
Baxter (BAX) United States $15.022B 9.77
Smith & Nephew SNATS (SNN) United Kingdom $10.471B 0.00
Bio-Rad Laboratories (BIO) United States $9.568B 32.52
BellRing Brands (BRBR) United States $9.145B 36.79
Demant (WILYY) Denmark $8.596B 0.00
Lantheus Holdings (LNTH) United States $6.666B 15.49
Haemonetics (HAE) United States $3.851B 18.79
ICU Medical (ICUI) United States $3.779B 35.98
Prestige Consumer Healthcare (PBH) United States $3.656B 18.18
Perrigo (PRGO) Ireland $3.326B 9.79
Envista Holdings (NVST) United States $3.198B 23.82
QuidelOrtho (QDEL) United States $3.077B 19.81
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
Neogen (NEOG) United States $2.678B 30.90
GN Store Nord (GNNDY) Denmark $2.593B 16.63
LeMaitre Vascular (LMAT) United States $2.104B 51.14
Green Thumb Industries (GTBIF) United States $1.564B 27.37
AtriCure (ATRC) United States $1.531B 0.00
AdaptHealth (AHCO) United States $1.364B 9.75
InMode (INMD) Israel $1.335B 8.03
BioLife Solutions (BLFS) United States $1.234B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.225B 0.00
Owens & Minor (OMI) United States $1.071B 8.37
Curaleaf Holdings (CURLF) Canada $0.942B 0.00
Phibro Animal Health (PAHC) United States $0.812B 14.32
CeriBell (CBLL) United States $0.750B 0.00
Evolus (EOLS) United States $0.633B 0.00
Capricor Therapeutics (CAPR) United States $0.600B 0.00
VAREX IMAGING (VREX) United States $0.551B 24.31
Surmodics (SRDX) United States $0.549B 0.00
Omeros (OMER) United States $0.512B 0.00
Cresco Labs (CRLBF) United States $0.459B 0.00
Verano Holdings (VRNOF) United States $0.423B 0.00
ZimVie (ZIMV) United States $0.372B 31.37
Valneva SE (VALN) France $0.369B 0.00
Quanterix (QTRX) United States $0.363B 0.00
Viemed Healthcare (VMD) United States $0.310B 29.44
Biote (BTMD) United States $0.307B 6.73
Cerus (CERS) United States $0.293B 0.00
Sanara MedTech (SMTI) United States $0.282B 0.00
OraSure Technologies (OSUR) United States $0.270B 18.10
Canopy Growth (CGC) Canada $0.267B 0.00
High Tide (HITI) Canada $0.250B 103.00
Zynex (ZYXI) United States $0.249B 52.20
Aurora Cannabis (ACB) Canada $0.227B 0.00
Sanuwave Health (SNWV) United States $0.224B 3.15
Utah Medical Products (UTMD) United States $0.207B 14.26
MacroGenics (MGNX) United States $0.200B 0.00
Organigram Holdings (OGI) Canada $0.198B 0.00
Brainsway (BWAY) Israel $0.177B 94.00
TerrAscend (TSNDF) Canada $0.164B 0.00
TriSalus Life Sciences (TLSI) United States $0.157B 0.00
FitLife Brands (FTLF) United States $0.137B 17.21
Quipt Home Medical (QIPT) United States $0.129B 0.00
Jin Medical (ZJYL) China $0.126B 0.00
Veru (VERU) United States $0.114B 0.00
Fonar (FONR) United States $0.096B 10.88
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
InterCure (INCR) Israel $0.076B 0.00
INLIF (INLF) $0.068B 0.00
Rockwell Medical (RMTI) United States $0.067B 34.67
Apyx Medical (APYX) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Exagen (XGN) United States $0.056B 0.00
Ayr Wellness (AYRWF) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
Modular Medical (MODD) United States $0.046B 0.00
Safety Shot (SHOT) United States $0.037B 0.00
Nephros (NEPH) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.30
SNDL (SNDL) Canada $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00